a year ago
NVAX
AnalystsBrendan SmithBrendan Smith's Stock Forecasts
AnalystsBrendan Smith
Sectors:
Industries:
Analyst Ranking
Top 44%
#2169 out of 4995 analysts
Average Return
+19.36%
Win Rate
75%3 out of 4
Risk vs Reward
Poor
Good
Brendan Smith's 5 best and worst ratings
Brendan Smith Analyst Color
Get additional color on Brendan Smith's coverage of popular stocks
Brendan Smith's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ginkgo Bioworks Holdings IncDNA | 1 | Strong Buy | $10.00 | -20.32% | Maintains | a year ago |
Halozyme Therapeutics IncHALO | 2 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Novavax IncNVAX | 1 | Hold | $10.00 | N/A | Maintains | a year ago |
Denali Therapeutics IncDNLI | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.